Safety Labeling Changes—Implementation of Section 505(o)(4) of the FD&C Act: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 18, 2025
September 18, 2025
2ed7dede-8a3f-4f38-baa2-5eec541a5edb
Related Documents
Postapproval Pregnancy Safety Studies Guidance for Industry
Guidance DocumentMay 9, 2019Center for Drug Evaluation and Research
Early Alzheimer’s Disease: Developing Drugs for Treatment
Guidance DocumentMarch 12, 2024Center for Drug Evaluation and Research
Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials
Guidance DocumentApril 9, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox